Samuels Noah, Schiff Elad, Lavie Ofer, Raz Orit Gressel, Ben-Arye Eran
Integrative Oncology Program, Oncology Service, Lin Medical Center Clalit Health Services, Haifa and Western Galilee District, Israel,
Support Care Cancer. 2015 Feb;23(2):317-24. doi: 10.1007/s00520-014-2361-6. Epub 2014 Jul 30.
The purpose of this study is to compare the rationale given by oncology health care practitioners (HCPs) for referral of their patients with breast cancer to a complementary medicine (CM) consultation with patient expectations from the CM treatment process.
We conducted a prospective, registry protocol-based, open-label study. We compared the indications given by oncology HCPs for their referral of patients to the CM consultation with patient expectations from the CM therapeutic process. Patients were asked regarding prior CM use for cancer- and non-cancer-related indications.
A total of 127 patients referred to the CM consultation were studied, with half reporting prior CM use. The most popular treatment for non-cancer-related indications was acupuncture (46.9 %), with only 20.3 % reporting herbal medicine use (P ≤ 0.04). For cancer-related indications, herbal medicine was the most popular modality (42.4 %), with 11.6 % reporting acupuncture use. The most frequently cited indications for referral were general symptom reduction (19.7 %), emotional/spiritual relief (18.1 %), alleviation of weakness and fatigue (17.3 %), and reduction of gastrointestinal symptoms (10.2 %). For patients, the most important outcome was alleviation of weakness and fatigue (70.4 %), followed by emotional/spiritual relief (50 %), and the reduction of gastrointestinal symptoms (33.3 %). The correlation between HCP indications for referral and patient expectations was poor (Cohen's kappa of 0.19, 0.328, and 0.20, respectively).
The findings suggest that expectations from a CM treatment process differ greatly between oncology HCPs and patients with breast cancer. The use of a structured clinical referral process and a better understanding of patient concerns are factors which play a central role in the CM referral process.
本研究旨在比较肿瘤医疗保健从业者(HCPs)将乳腺癌患者转诊至补充医学(CM)咨询的理由与患者对CM治疗过程的期望。
我们进行了一项前瞻性、基于注册协议的开放标签研究。我们比较了肿瘤HCPs将患者转诊至CM咨询的指征与患者对CM治疗过程的期望。询问患者先前使用CM治疗癌症及非癌症相关指征的情况。
共研究了127名转诊至CM咨询的患者,其中一半报告曾使用过CM。非癌症相关指征最常用的治疗方法是针灸(46.9%),只有20.3%的患者报告使用过草药(P≤0.04)。对于癌症相关指征,草药是最常用的治疗方式(42.4%),11.6%的患者报告使用过针灸。转诊最常提及的指征是减轻一般症状(19.7%)、缓解情绪/精神问题(18.1%)、减轻虚弱和疲劳(17.3%)以及减轻胃肠道症状(10.2%)。对患者而言,最重要的结果是减轻虚弱和疲劳(70.4%),其次是缓解情绪/精神问题(50%)以及减轻胃肠道症状(33.3%)。HCPs转诊指征与患者期望之间的相关性较差(科恩kappa系数分别为0.19、0.328和0.20)。
研究结果表明,肿瘤HCPs与乳腺癌患者对CM治疗过程的期望存在很大差异。采用结构化的临床转诊流程以及更好地理解患者的担忧是CM转诊过程中的关键因素。